Seeking Alpha

Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing...

Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing that its weight-loss drug Qsymia was available in the U.S. market. The announcement was also made on its website, Qsymia.com. Peer competitor Arena Pharmaceuticals (ARNA +1%) also gets a lift on the news, in spite of the fact that its weight-loss drug, Belviq, won't be available until 2013.
Comments (7)
  • phemale60
    , contributor
    Comments (2833) | Send Message
     
    Adam's comments (I found interesting) on both companies at upcoming obesity conference:

     

    http://bit.ly/RjE3Vh
    17 Sep 2012, 12:53 PM Reply Like
  • shareholderhelp
    , contributor
    Comments (7) | Send Message
     
    This is great news as it will give VVUS an opportunity to show its side effects well before Arena's Belviq and bring those people over to Belviq when it hits the market.
    17 Sep 2012, 01:24 PM Reply Like
  • phemale60
    , contributor
    Comments (2833) | Send Message
     
    Hah, whatever!
    17 Sep 2012, 02:57 PM Reply Like
  • New Superhuman
    , contributor
    Comments (1182) | Send Message
     
    How is it possible that VVUS beat ARNA to market? Wasn't the ruling on VVUS delayed?
    18 Sep 2012, 04:01 AM Reply Like
  • phemale60
    , contributor
    Comments (2833) | Send Message
     
    No! Seems you're misinformed. But then Areniacs count on that hoping to drown Qsymia in quicksand while Belviq sits in sun alone! LOL ;-)
    18 Sep 2012, 12:52 PM Reply Like
  • LooseChange
    , contributor
    Comments (79) | Send Message
     
    Hey New Superhuman . . . Hello!

     

    QUOTE: "How is it possible that VVUS beat ARNA to market? Wasn't the ruling on VVUS delayed?"

     

    You're right that the FDA ruling was delayed. BUT the truly superhuman management of Vivus had the courage to bet the whole doggone farm in anticipation of approval. For a couple of months earlier this year, they issued and sold new stock for a measly $22 PPS in order to bankroll the creation of a huge national sales department. I've forgotten the details, but I do recall that the Vivus company (only 40 employes just a few months ago) is now "loaded for bear" and ready to explode.
    19 Sep 2012, 11:52 PM Reply Like
  • phemale60
    , contributor
    Comments (2833) | Send Message
     
    "now 'loaded for bear' and ready to explode"

     

    LooseChange, even now after the EU disappointment? I think the drug is going to be a blockbuster but for now I need to know!
    24 Sep 2012, 01:25 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector